Literature DB >> 10026190

A soluble form of the avian hepatitis B virus receptor. Biochemical characterization and functional analysis of the receptor ligand complex.

S Urban1, C Kruse, G Multhaup.   

Abstract

Avian hepatitis B virus infection is initiated by the specific interaction of the extracellular preS part of the large viral envelope protein with carboxypeptidase D (gp180), the primary cellular receptor. To functionally and biochemically characterize this interaction, we purified a soluble form of duck carboxypeptidase D from a baculovirus expression system, confirmed its receptor function, and investigated the contribution of different preS sequence elements to receptor binding by surface plasmon resonance analysis. We found that preS binds duck carboxypeptidase D with a 1:1 stoichiometry, thereby inducing conformational changes but not oligomerization. The association constant of the complex was determined to be 2.2 x 10(7) M-1 at 37 degreesC, pH 7.4, with an association rate of 4.0 x 10(4) M-1 s-1 and a dissociation rate of 1.9 x 10(-3) s-1, substantiating high affinity interaction of avihepadnaviruses with their receptor carboxypeptidase D. The separately expressed receptor-binding domain, comprising about 50% of preS as defined by mutational analysis, exhibits similar constants. The domain consists of an essential element, probably responsible for the initial receptor contact and a part that contributes to complex stabilization in a conformation sensitive manner. Together with previous results from cell biological studies these data provide new insights into the initial step of hepadnaviral infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026190     DOI: 10.1074/jbc.274.9.5707

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Receptor recognition by a hepatitis B virus reveals a novel mode of high affinity virus-receptor interaction.

Authors:  S Urban; C Schwarz; U C Marx; H Zentgraf; H Schaller; G Multhaup
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

Review 2.  Viral and cellular determinants involved in hepadnaviral entry.

Authors:  Dieter Glebe; Stephan Urban
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

3.  Mapping of the hepatitis B virus pre-S1 domain involved in receptor recognition.

Authors:  Azeneth Barrera; Bernadette Guerra; Lena Notvall; Robert E Lanford
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

4.  A hydrophobic domain in the large envelope protein is essential for fusion of duck hepatitis B virus at the late endosome.

Authors:  J Chojnacki; D A Anderson; E V L Grgacic
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  Inhibition of duck hepatitis B virus infection by a myristoylated pre-S peptide of the large viral surface protein.

Authors:  Stephan Urban; Philippe Gripon
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Carboxypeptidase D (gp180), a Golgi-resident protein, functions in the attachment and entry of avian hepatitis B viruses.

Authors:  K M Breiner; S Urban; H Schaller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Avian hepatitis B virus infection is initiated by the interaction of a distinct pre-S subdomain with the cellular receptor gp180.

Authors:  S Urban; K M Breiner; F Fehler; U Klingmüller; H Schaller
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

8.  Cellular receptor traffic is essential for productive duck hepatitis B virus infection.

Authors:  K M Breiner; H Schaller
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

9.  Envelope protein-mediated down-regulation of hepatitis B virus receptor in infected hepatocytes.

Authors:  K M Breiner; S Urban; B Glass; H Schaller
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 10.  Phage display creates innovative applications to combat hepatitis B virus.

Authors:  Wen Siang Tan; Kok Lian Ho
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.